< Back to search
Filter
1

Metabolically Fit CD19 CAR T-cell Therapy With CD34 Selection in Patients With CD19+ Relapsed/Refractory NHL, CLL/SLL

for
B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia
Location: Charleston SC
Sponsor: Medical University of South Carolina

Sex: All

Age: 18+

Code: NCT05702853

Phase1, Phase2, Recruiting

Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy

for
Breast Cancer, Lymphoma
Location: Oklahoma City OK
Sponsor: University of Oklahoma

Sex: All

Age: 18 - 70+

Code: NCT05921253

Early_phase1, Recruiting

Sonrotoclax, Rituximab, and Zanubrutinib in Treating Participants With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Mantle Cell Lymphoma

for
Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT06839053

Phase2, Recruiting

Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)

for
Breast Cancer, Colorectal Cancer, Pancreas Cancer,
Location: Kingston, Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT05403177

Recruiting

CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/Refractory B Cell Malignancies

for
Recurrent B-Cell Non-Hodgkin Lymphoma,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT04892277

Phase1, Recruiting

Interested in new lymphoma trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies

for
Central Nervous System Lymphoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05011045

Recruiting

B-Cell Activating Factor Receptor (BAFFR)-Based Chimeric Antigen Receptor T-Cells With Fludarabine and Cyclophosphamide Lymphodepletion for the Treatment of Relapsed or Refractory B-cell Hematologic Malignancies

for
B-Cell Non-Hodgkin Lymphoma,
Location: Jacksonville FL
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06191887

Phase1, Recruiting

Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma

for
NK-Cell Lymphoma, NK-Cell Leukemia, Peripheral T Cell Lymphoma
Location: Valhalla NY, Columbus OH, Grand Rapids MI,
Sponsor: New York Medical College

Sex: All

Age: 1 - 31

Code: NCT03719105

Early_phase1, Recruiting

A Phase 2 Trial of Mosunetuzumab and Zanubrutinib for Patients With Relapsed/Refractory Marginal Zone Lymphoma

for
Lymphoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06563505

Phase2, Recruiting

Tissue Collection for Studies of Lymph Cancer

for
Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT01676805

Recruiting

Collection of Tissue Samples for Cancer Research

for
Neoplasms, Lymphomas, Multiple Myeloma,
Location: Baltimore MD, Bethesda MD, Buffalo NY, Pittsburgh PA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0+

Code: NCT00900198

Recruiting

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

for
Haematological Malignancy, Acute Myeloid Leukemia,
Location: Philadelphia PA, Bethesda MD, Atlanta GA,
Sponsor: CellCentric Ltd.

Sex: All

Age: 18+

Code: NCT04068597

Phase1, Phase2, Recruiting

Epcoritamab for the Treatment of Relapsed or Refractory Post Transplant Lymphoproliferative Disorders

for
Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder,
Location: Columbus OH, St Louis MO
Sponsor: Timothy Voorhees

Sex: All

Age: 18+

Code: NCT06672705

Phase1, Recruiting

Evaluation of Bridging Radiation Therapy Before CAR T-Cell Infusion for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma

for
Recurrent Diffuse Large B-Cell Lymphoma,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT05800405

Early_phase1, Recruiting

Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)

for
Lymphoma, Lymphoma, B-Cell
Location: New York NY
Sponsor: Jennifer Amengual

Sex: All

Age: 15+

Code: NCT06954805

Phase2, Recruiting

CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30)

for
Hodgkin's Lymphoma, Non-Hodgkin Lymphoma
Location: Houston TX
Sponsor: Baylor College of Medicine

Sex: All

Age: 12 - 70+

Code: NCT02917083

Phase1, Recruiting

This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors

for
Non Small Cell Lung Cancer,
Location: Boston MA, Austin, TX 78758 TX, San Antonio TX
Sponsor: Zumutor Biologics Inc.

Sex: All

Age: 18+

Code: NCT06451497

Phase1, Recruiting

Allo HSCT Using RIC and PTCy for Hematological Diseases

for
Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia,
Location: Minneapolis MN
Sponsor: Masonic Cancer Center, University of Minnesota

Sex: All

Age: 0 - 70+

Code: NCT05805605

Phase2, Recruiting

A Study of Ruxolitinib and Duvelisib in People With Lymphoma

for
T-cell Lymphomas, NK-Cell Lymphomas,
Location: Boston MA, Commack NY, Uniondale NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT05010005

Phase1, Recruiting

Hyperfractionated Dual Equivalent Fractionated Radiation Therapy

for
Diffuse Large B-Cell Lymphoma
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT06898905

Recruiting